Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Nateglinide preclinical and clinical data featured at diabetes meeting

Sep. 14, 1998

Heart valve abnormalities a problem among appetite suppressant-treated obese patients

Sep. 14, 1998

U.K. filing announced for MED treatment option

Sep. 11, 1998

Clinical studies on Hoe-901 reported at European diabetes meeting

Sep. 11, 1998

Amgen initiates clinical trials of novel bone protective agent

Sep. 11, 1998

Biaryl uricosuric agents developed at Kotobuki

Sep. 11, 1998

Exendin-4 inhibits feeding in rats, indicating potential utility for appetite control in humans

Sep. 10, 1998

Efficacy of thiazolidinedione rosiglitazone highlighted at diabetes meeting

Sep. 10, 1998

Ixion receives patent allowance for technology to treat oxalate-related disorders

Sep. 10, 1998

Upregulators of LDL receptor in development at Pfizer as hypocholesterolemic agents

Sep. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...